GlobeStar Therapeutics Corp Quarterly Entity Common Stock, Shares Outstanding from Q2 2011 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
GlobeStar Therapeutics Corp quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q2 2011 to Q3 2024.
  • GlobeStar Therapeutics Corp Entity Common Stock, Shares Outstanding for the quarter ending October 4, 2024 was 1.24B shares.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 1.24B Oct 4, 2024 10-Q 2024-10-11
Q2 2024 1.24B +453M +57.6% Jun 21, 2024 10-Q 2024-06-28
Q1 2024 1.16B Mar 11, 2024 10-Q 2024-03-12
Q4 2023 1.03B +256M +33.2% Jan 16, 2024 10-K 2024-01-19
Q2 2023 788M +145M +22.5% May 25, 2023 10-Q 2023-05-31
Q4 2022 770M +170M +28.3% Jan 3, 2023 10-K 2023-01-09
Q3 2022 694M +148M +27% Aug 22, 2022 10-Q/A 2022-08-23
Q2 2022 643M +167M +35.2% May 23, 2022 10-Q 2022-06-01
Q4 2021 600M +134M +28.7% Dec 27, 2021 10-K 2022-01-05
Q3 2021 546M Aug 20, 2021 10-Q 2021-08-23
Q2 2021 476M +92.5M +24.1% May 20, 2021 10-Q 2021-05-21
Q4 2020 466M +256M +122% Jan 26, 2021 10-Q 2021-01-28
Q2 2020 383M +254M +197% Jul 14, 2020 10-Q 2020-07-14
Q1 2020 319M +213M +200% May 4, 2020 10-Q 2020-05-05
Q4 2019 210M +125M +147% Dec 30, 2019 10-K 2019-12-31
Q2 2019 129M +65.8M +104% Jul 26, 2019 10-Q 2019-08-02
Q1 2019 106M May 14, 2019 10-Q 2019-05-15
Q4 2018 85.1M +39M +84.6% Dec 31, 2018 10-K 2019-01-03
Q2 2018 63M +21.9M +53.4% Jul 31, 2018 10-Q 2018-08-01
Q4 2017 46.1M Jan 10, 2018 10-K 2018-01-16
Q3 2017 41.1M +9.56M +30.3% Aug 18, 2017 10-Q/A 2017-08-23
Q2 2017 41.1M +31.1M +310% May 19, 2017 10-Q 2017-05-19
Q1 2017 38.8M +28.9M +292% Mar 28, 2017 10-K 2017-03-29
Q3 2016 31.5M Sep 13, 2016 10-Q/A 2016-09-16
Q2 2016 10M +2.39M +31.3% May 17, 2016 10-Q/A 2016-06-16
Q1 2016 9.9M -25.4M -72% Feb 16, 2016 10-Q 2016-02-22
Q4 2015 9.74M -18.3M -65.2% Jan 11, 2016 10-K/A 2016-01-22
Q2 2015 7.63M -14.1M -64.9% Aug 13, 2015 10-Q/A 2015-09-24
Q1 2015 35.3M +19.2M +119% May 15, 2015 10-Q/A 2015-09-17
Q4 2014 28M +16.2M +136% Jan 12, 2015 10-K/A 2015-01-27
Q2 2014 21.8M +12.5M +135% Aug 12, 2014 10-Q/A 2014-09-04
Q1 2014 16.1M +6.85M +73.9% May 15, 2014 10-Q 2014-05-20
Q4 2013 11.9M +5.37M +82.6% Jan 9, 2014 10-K/A 2014-01-23
Q2 2013 9.26M -4.44M -32.4% Jul 31, 2013 10-Q 2013-08-14
Q1 2013 9.26M May 14, 2013 10-Q/A 2013-05-16
Q4 2012 6.5M -5.5M -45.9% Jan 9, 2013 10-K/A 2013-03-07
Q2 2012 13.7M +1.7M +14.2% Jul 31, 2012 10-Q/A 2012-09-20
Q4 2011 12M Dec 22, 2011 10-K 2011-12-29
Q2 2011 12M Jun 30, 2011 10-Q 2011-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.